Literature DB >> 11390567

The endogenous mammary gland Na(+)/I(-) symporter may mediate effective radioiodide therapy in breast cancer.

L S Zuckier, E Dadachova, O Dohan, N Carrasco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390567

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  2 in total

1.  Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.

Authors:  J K Joseph; R B Patel; A A Damle; N Nair; R A Badwe; S Basu
Journal:  Indian J Surg Oncol       Date:  2013-01-05

2.  The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation.

Authors:  Hani Alotaibi; Merve Tuzlakoğlu-Öztürk; Uygar Halis Tazebay
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.